Rotheca myricoides
Rotheca myricoides, commonly known as a significant medicinal herb, is a plant valued for its diverse therapeutic properties. Found in specific tropical regions, it is traditionally utilized in folk medicine to treat various ailments. Understanding its chemical composition and pharmacological potential is essential for modern botanical and clinical research.
- Scientific name: Rotheca myricoides
- Family: Lamiaceae
- Native range: Africa
Taxonomical Classification
This plant belongs to the kingdom Plantae and is classified under the phylum Streptophyta and class Equisetopsida. Within the subclass Magnoliidae, it is further categorized under the order Lamiales and the family Lamiaceae. Ultimately, its taxonomic identity is defined by its placement in the genus Rotheca.
| Rank | Classification | Source |
|---|---|---|
| Kingdom | Plantae | WCVP |
| Phylum | Streptophyta | WCVP |
| Class | Equisetopsida | WCVP |
| Subclass | Magnoliidae | WCVP |
| Order | Lamiales | WCVP |
| Family | Lamiaceae | WCVP |
| Genus | Rotheca | WCVP |
Common Names
This plant, known scientifically as Rotheca myricoides, is referred to by various common names depending on the linguistic and regional context. In Chinese, it is known as 蓝蝴蝶 or 杨梅叶大青, with the specific traditional character forms appearing as 藍蝴蝶 in Taiwan (zh-tw) and 蓝蝴蝶 in mainland China (zh-cn). In Japanese, it is transliterated as ロテカ・ミリコイデス.| Language | Common Name | Source |
|---|---|---|
| zh | 蓝蝴蝶 | Wikidata |
| zh-cn | 蓝蝴蝶 | Wikidata |
| zh-tw | 藍蝴蝶 | Wikidata |
| ja | ロテカ・ミリコイデス | Wikidata |
| zh | 杨梅叶大青 | Wikidata |
| af | Growweblaarkatsnorbosse | Wikidata |
Distribution
This plant exhibits a specific distribution pattern across various regions of the African continent. In West-Central Tropical Africa, its presence is documented in Burundi, Rwanda, and the Democratic Republic of the Congo. The species also extends into Northeast Tropical Africa, where it can be found in Djibouti. Additionally, its range includes the nation of Eritrea within the northeastern zone. Collectively, these locations highlight a habitat spanning both West-Central and Northeast tropical territories.
| Region | Area | Source |
|---|---|---|
| West-Central Tropical Africa | Burundi | WCVP |
| West-Central Tropical Africa | Rwanda | WCVP |
| West-Central Tropical Africa | DR Congo | WCVP |
| Northeast Tropical Africa | Djibouti | WCVP |
| Northeast Tropical Africa | Eritrea | WCVP |
| Northeast Tropical Africa | Ethiopia | WCVP |
| Northeast Tropical Africa | Somalia | WCVP |
| Northeast Tropical Africa | Sudan-South Sudan | WCVP |
| East Tropical Africa | Kenya | WCVP |
| East Tropical Africa | Tanzania | WCVP |
Plant Parts
This plant, Rotheca myricoides, utilizes its specialized anatomical structures to support its biological functions, with its root system serving as a fundamental component for stability and nutrient absorption. Although the specific medicinal applications can vary depending on traditional practices, the root acts as the primary anchor and the site for storing essential compounds necessary for the plant's survival.- Total parts
- 2
- Scientific sources
- 2
| Plant Part | Sources | Confidence |
|---|---|---|
| root | 1 | ★☆☆☆☆ |
| RB | 1 | ★☆☆☆☆ |
Activities
Rotheca myricoides has 1 reported activities identified across 1 scientific publications and several other databases. The most consistently reported activities include Antimutagenic.
- Total activities
- 1
- Scientific sources
- 1
Most Reported Activities
| Activity | Sources | Confidence |
|---|---|---|
| Antimutagenic | 1 | ★☆☆☆☆ |
Medicinal Uses
Rotheca myricoides has 7 reported medicinal uses identified across 7 scientific publications and several other databases. The most consistently reported uses include COVID-19, HIV, MERS-CoV, SARS-CoV, SARS-CoV-2.
- Total uses
- 7
- Scientific sources
- 7
Most Reported Uses
| Use | Sources | Confidence |
|---|---|---|
| COVID-19 | 1 | ★☆☆☆☆ |
| HIV | 1 | ★☆☆☆☆ |
| MERS-CoV | 1 | ★☆☆☆☆ |
| SARS-CoV | 1 | ★☆☆☆☆ |
| SARS-CoV-2 | 1 | ★☆☆☆☆ |
| diseases | 1 | ★☆☆☆☆ |
| immunocompromised patients | 1 | ★☆☆☆☆ |